Any ideas anyone?

I wonder that we shouldn't be so narrow in our view - if the drug works there is a Market (it may take some finding) - generally in the US where the drug Market is 10x UK size.
It is difficult to understand why the sp has stuck to the 85/90p range, but the same thing happened with Cobra - - sales slumped in line with expectations, yet the Market thinks "this is dire" and the sp fell from over 1 to close on 25p - picking some of these was a no-brainer and reading their annual Report (1year on)shows the US willing to use their services. Hopefully [CBF] Management will have learnt their lesson = Don't worry the Market.

PYM maybe has something to learn, but we'll be seeing a gradual improvement in sp since I doubt there is any further "bad news" and gradually folk will recognise this isn't a 1-product co. (however, the market for Hoodia is being queered IMHO by July reports that Kings College (is it?) has discovered a way to cheat the stomach) - KC are in early trials - so aren't they re-inventing Hoodia? The difference being, Hoodia has been trialed in humans for 100's of years [admitedly not western clinical] but if you get to a well to drink, as others are leaving with their water bottles full, you'd be tempted to slake your thirst; I would.

Finally, this Government may be further cheating the elderly (like the tax-credits on dividends, etc.) but that doesn't mean there won't be a UK demand, provided PYM can get them early enough - so they can make an informed choice!
/Regards.

I'm tempted to buy. Just not sure if all the bad news is in the price - losing their Japanese contract, their broker etc.

Even if the UK gov will not oblige future Alzheimers patients, USA will, as seen yesterday in the deal with Regentherapeutics.

More buyers than sellers today.

any views on this

My position hasn't changed, but telephone the company for the latest news - I think the Animal rights issue is still a concern (although I fail to see why PYM is involved, the so-called association with HLS is really pretty thin IMHO - these activists need culling unless they adopt purely peaceful tactics - maybe the 90days would help, but I suspect there is no Police activity until it become a National Issue)
I suspect this is at the heart of the sp fall.......but new investors can still buy for ISA - that affords some protection I guess.....but the loss of a Broker/adviser is really not an issue - it just makes other investors more nervous.
Obesity is likely to kill many people with the knock-on effect on families - so the success of their No1 product is (almost) G'teed - what hasn't been demonstrated is how much PYM will make (in cash). I have a few ini an old PEP at about 90p so almost evens....

Where next any one

I'm not sure what's holding this back - at current levels they are historically as cheap as _ . However, their time to Market seems to be getting longer (or punters like myself got too excited) - they have a vetinary product that's looking good (ie cash generating as soon as the boxes are printed) - and they have an obesity product that is soon to undergo trial in its final form (a Unilever food, I understand)
although real-sales are unlikely before 2008....The "risk" with this type of product is munute IMHO - Unilever don't go with duds. Of course we have to wait and see what Royalties roll in.....
...and there is an asthma product moving along - anyone wanting a sure-fire stock to tuck nto an ISA - look no further.
Yes I do hold, from somewhat higher - and have bought recently at 50p - well, let's hear from others - what's the problem?

problem is with small cap stocks when newsflow fades the stock ticks slowly south. players become stale. if a stock is worth holding,it must equally be worth buying! bought at a pound or 50p pym is good value. this stock i consider to be my least speculative play hangon hangon!

PYM is really cheap at the mo... big money to be made, i bought 4000 on monday on an opening low, already 8.9% up... strang that the price was dropping on monday even though there were a lot more buys than sells... is there something i do not know... Or is it just because the market makers had too many shares, and sold them off cheap?

Still think that these shares are really hot... They have had a lot of bad news which has created bad sentiment.... Always good to by on bad sentiment, since the shares have a much higher real value... THESE SHARES ARE REALLY UNDERVALUED

I fear you are telling us what we want to believe....where is your evidence that these shares are hot (and comfirm you mean "good to buy now")...please?
/
Over recent weeks the sp has stabalised about the 50p mark, but that's becasue there is cash to last a little longer and there is every chance they will generate some income, thereby avoiding the need to tap the Market......but "hot"? I fear not - more like "not stone cold".
/
Should the worst happen and they need more cash ( This might be for another line of product/research) -I can see retail investors, like thee and me, being diluted and it is this fear (I presume) along with expectation of delays until 2008 that is holding-back Buying......your investment is fairly safe IMHO, but I don't see this high temperature, please explain.
Many here will have been nursing losses from 2.

I am not a market expert, but PYM turnover jumped up early november. Do you think interest might be increasesd from Hoodia project? as soon as more info comes through....

PYM did a Rights Issue last year so they have some on-going cash - and there was a Unilever deal as well as a vetinary product (could this be the confusion for Animal Rights activity?) - this product is FOR animals to improve their life against itchy skin - which I understand has no alternative cure.....so there.....DYOR as ever.
/
SP fallen today on little News (indeed PYM is reccommended for anyone with a hearing problem).......but it's darn close to a 12 month Low - and that was the lowest it's been for ages.
/
I suppose I have to ask myself Do I feel Lucky - is the Co about to fold? .....Arrgh.
- Still, I hold in hope......maybe being a little silly, eh?
Currently 42p-ish

Hoodia - I've looked at Slim-fash (google) and it is a Unilever "brand" so it's possible this is the brand that will take the hoodia product......but there is no mention of this by Unilever.......and other related sites don't mention hoodia.....so does anyone know for certain where we should look for Unilever info on Release Dates, product prices etc?

brief news article regarding appetite suppressants. from extreme surgical methods to a new product shortly to be available from unilever which induces the sensation of afull stomach. re:lbc 1152 thur 23 am. assume this is hoodia

Share price seems to be falling still...

Excellent article on this site. At least they talked to the company before writing.

Just need an email address to register.

Phytopharm:
Is Phytopharm damaged goods?
(Mar 2006)

In theory Phytopharm has an interesting business plan - develop pharmaceutical drugs based on research into plant extracts from which drug candidates can be purified

http://www.proactiveinvestors.com

some good news today... but will it hold up this time, this share likes to break north very quickerly, the same way it falls... keep an eye on these ones

I had to buy in on these ones... feel the time is right. Results will be out on the Monday 8 May 2006. There will be some sepeculation that the results should be good, possible some profit. This was the recent news release;


Under the terms of the agreement, Phytopharm and Unilever are collaborating on a
five-stage research and development programme of safety and efficacy studies
with a view to bringing new weight management products to market. As part of the
agreement announced in December 2004, Unilever committed to initial payments of
approximately 6.5 million for the first stage and for the second stage have now
committed to a further 3.5 million out of a potential total of 21 million in
payments to Phytopharm. In addition Phytopharm will receive an undisclosed
royalty on sales of all products containing the extract. Unilever is also
managing a separate agronomy programme and supporting the international patent
programme for the products.

Phytopharm licensed the global patent rights for the extract of Hoodia gordonii,
a plant indigenous to South Africa, for incorporation into weight loss products
from the South African Council for Scientific and Industrial Research (CSIR) in
1997.

I would welcome other peoples comments on this company... Shares mag has made a buy recommendation

these shares are booming, I am not a glory hunter but think i was right about there move north, I am going to stock up

up 13% today

Also large x trade went through today, 2,459,817 shares in this one deal... past experiance tells me that whenever a large x trade goes through on a penny share it is a good signal... we will have to wait and see but i feel this one should be in your watchlist... there is a separate thread about large x trades, but can not remember its title, sorry..... comments?